Reliability of Functional Outcome Measures in Plantar Fascitis Patients

January 21, 2012 updated by: Uzi Milman, Clalit Health Services

Plantar Fasciitis (PF) is the most common foot condition treated by healthcare providers, striking approximately 2 million Americans each year. Nevertheless its causes are still not known. The risk factors for PF are known and the diagnosis, which is based on clinical assessment, is relatively simple. Still most of the treatments for PF focus on short term symptoms relief instead of prevention or reduction of recurrence.

Physical therapy treatment that focuses on reducing the symptoms for the long run and prevention, should include outcome measures, which if found to be reliable, will make the diagnosis clearer. Diagnosis based on reliable clinical and functional measures will assist the physical therapist to understand the major deficiencies of the patient, and accordingly to help him to make the right decision in choosing treatment. Also comprehensive knowledge of the characteristics of PF may enable selection of appropriate preventive measures.

Study Overview

Status

Completed

Conditions

Detailed Description

Objectives:

Characterize the unilateral PF syndrome using functional outcome measures, while comparing them to the healthy foot of the same patient. In addition the study will investigate the reliability of these functional outcome measures in PF patients.

Methodology:

Individuals referred to physiotherapy for PF will be assessed for eligibility and consent for the study. They will undergo two evaluations on the same week to evaluate the test- retest reliability of the functional measurements.

Study Type

Observational

Enrollment (Anticipated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Haifa, Israel
        • Clalit Health Services, Haifa and Western Galilee District

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Individuals referred to community physiotherapy center for plantar Fasceitis treatment.

Description

Inclusion Criteria:

  • Unilateral plantar fasciitis
  • Painful first step in the morning
  • Calcaneal soreness in palpation
  • Insured by Clalit Health Care Services
  • Signed informed consent

Exclusion Criteria:

  • Ankle or foot surgery
  • Congenital deformation of foot
  • Lower limb spasticity
  • Using assistive devices
  • Bilateral plantar fasciitis
  • Refuse to participate or sign informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Limitation
Time Frame: 1 week
Measurement of Functional Limitation using Foot Function Index (FFI) compared to the healthy foot
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: 1 week
Measurement of pain intensity using visual analog scale (VAS), compared to the healthy foot
1 week
Pain threshold
Time Frame: 1 week
Measurement of pain threshold using a Pressure Algometer, compared to the healthy foot
1 week
Muscle strength
Time Frame: 1 week
Measurement of Muscle strength in Plantar Flexion and Dorsi Flexion using Hand Held Dinamometer - compared to the healthy foot.
1 week
Range of motion
Time Frame: 1 week
Measurement of Range of motion using a Digital inclinometer - compared to the healthy foot
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Uzi Milman, MD, Clinical Research Unit, Clalit Health Services, Haifa District, HAIFA, ISRAEL
  • Principal Investigator: HASAN KHAIRELDIN, MD, Clinical Research Unit, Clalit Health Services, Haifa District, HAIFA, ISRAEL
  • Principal Investigator: SHARON ISRAELY, BA, Clinical Research Unit, Clalit Health Services, Haifa District, HAIFA, ISRAEL

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2010

Primary Completion (Actual)

May 1, 2011

Study Completion (Actual)

May 1, 2011

Study Registration Dates

First Submitted

May 24, 2010

First Submitted That Met QC Criteria

June 15, 2010

First Posted (Estimate)

June 16, 2010

Study Record Updates

Last Update Posted (Estimate)

January 24, 2012

Last Update Submitted That Met QC Criteria

January 21, 2012

Last Verified

January 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • K-10-0037-ctil

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Plantar Fasciitis

Subscribe